Literature DB >> 19261369

Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India.

Anis Ahmad1, Asad U Khan.   

Abstract

OBJECTIVES: The objectives were to determine the frequency of Candida species in women of different age groups as well as to suggest the criteria for the diagnosis of vulvovaginal candidiasis (VVC). STUDY
DESIGN: A prospective study of vulvovaginal candidiasis was carried out using laboratory diagnosis, with the estimation of vaginal pH and the direct microscopic and biochemical examination of vaginal discharge/secretions. Vaginal cultures for Candida species were collected from 1050 women with vulvovaginal symptoms.
RESULTS: Out of 1050 women, 215 (20.47%) were positive for Candida species. Of 215 women, 172 (80%) had pH within the normal range and 167 (77.67%) were showing yeast cells and mycelia on direct microscopic examination. Candida albicans accounted for 46.9% of cases, Candida glabrata 36.7%, Candida parapsilosis 10.2%, Candida tropicalis 2.8%, Candida krusei 1.4%, and Candida kiefer 1.9%. The frequency of culture positivity was related to pregnancy (P<0.001), an increase in parity (P<0.001), and use of oral contraceptives (P<0.001) and antibiotics (P<0.001). The most common signs and symptoms in 215 women with positive cultures were pruritus with or without vaginal discharge and vaginal erythema.
CONCLUSION: Our study suggests that vulvovaginal candidiasis can only be diagnosed by using clinical criteria in correlation with vulvovaginal symptoms and Candida cultures.

Entities:  

Mesh:

Year:  2009        PMID: 19261369     DOI: 10.1016/j.ejogrb.2008.12.020

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  36 in total

1.  Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New Insights.

Authors:  Melissa A Kennedy; Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

2.  Comparison of the therapeutic effects of Garcin(®) and fluconazole on Candida vaginitis.

Authors:  Farzaneh Ebrahimy; Mahrokh Dolatian; Fariborz Moatar; Hamid Alavi Majd
Journal:  Singapore Med J       Date:  2015-10       Impact factor: 1.858

Review 3.  Candida infections of the genitourinary tract.

Authors:  Jacqueline M Achkar; Bettina C Fries
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 4.  Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment.

Authors:  Natália Martins; Isabel C F R Ferreira; Lillian Barros; Sónia Silva; Mariana Henriques
Journal:  Mycopathologia       Date:  2014-05-01       Impact factor: 2.574

Review 5.  Candida parapsilosis Vaginal Infection-a New Site of Azole Drug Resistance.

Authors:  J D Sobel; S Suprapaneni
Journal:  Curr Infect Dis Rep       Date:  2018-08-27       Impact factor: 3.725

6.  Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis.

Authors:  E P Garvey; W J Hoekstra; R J Schotzinger; J D Sobel; E A Lilly; P L Fidel
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

7.  Fungal Profile of Vulvovaginal Candidiasis in a Tertiary Care Hospital.

Authors:  Krishnapriya Kalaiarasan; Rakesh Singh; Latha Chaturvedula
Journal:  J Clin Diagn Res       Date:  2017-03-01

8.  Phenotypic Characterization and Antifungal Susceptibility Pattern to Fluconazole in Candida species Isolated from Vulvovaginal Candidiasis in a Tertiary Care Hospital.

Authors:  Latha Ragunathan; G K Poongothai; Annie Rofeena Sinazer; Kavitha Kannaiyan; Hemalatha Gurumurthy; Nirmala Jaget; Sethumadhavan Kuthalaramalingam
Journal:  J Clin Diagn Res       Date:  2014-05-15

9.  Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.

Authors:  B Minea; V Nastasa; R F Moraru; A Kolecka; M M Flonta; I Marincu; A Man; F Toma; M Lupse; B Doroftei; N Marangoci; M Pinteala; T Boekhout; M Mares
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-16       Impact factor: 3.267

10.  Antifungal profile of vulvovaginal candidiasis in sexually active females from a tertiary care hospital of Western Rajasthan.

Authors:  Sarika P Kombade; Kumar S Abhishek; Payal Mittal; Charu Sharma; Pratibha Singh; Vijaya L Nag
Journal:  J Family Med Prim Care       Date:  2021-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.